[go: up one dir, main page]

RU95113157A - Новые аналоги витамина d, способ их получения, фармацевтическая композиция на их основе, способ лечения и профилактики патологических состояний - Google Patents

Новые аналоги витамина d, способ их получения, фармацевтическая композиция на их основе, способ лечения и профилактики патологических состояний

Info

Publication number
RU95113157A
RU95113157A RU95113157/04A RU95113157A RU95113157A RU 95113157 A RU95113157 A RU 95113157A RU 95113157/04 A RU95113157/04 A RU 95113157/04A RU 95113157 A RU95113157 A RU 95113157A RU 95113157 A RU95113157 A RU 95113157A
Authority
RU
Russia
Prior art keywords
methylene
prophylaxis
medical treatment
pathological states
analogue
Prior art date
Application number
RU95113157/04A
Other languages
English (en)
Other versions
RU2128168C1 (ru
Inventor
Джон Кэлверли Мартин
Gb]
Педерсен Хенрик
Dk]
Original Assignee
Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) (Dk)
Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) (Dk), Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) filed Critical Лео Фармасьютикал Продактс Лтд. А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) (Dk)
Publication of RU95113157A publication Critical patent/RU95113157A/ru
Application granted granted Critical
Publication of RU2128168C1 publication Critical patent/RU2128168C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретение относится к соединениям формулы, приведенной в описании. Соединения обладают противовоспалительным и иммуномодулирующим действием, а также высокой активностью в индуцировании, дифференциации и торможении нежелательной пролиферации некоторых клеток.

Claims (1)

  1. Изобретение относится к соединениям формулы, приведенной в описании. Соединения обладают противовоспалительным и иммуномодулирующим действием, а также высокой активностью в индуцировании, дифференциации и торможении нежелательной пролиферации некоторых клеток.
RU95113157A 1992-11-04 1993-11-01 Аналоги витамина d3, способы из получения, фармацевтическая композиция и способ лечения RU2128168C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9223061.4 1992-11-04
GB929223061A GB9223061D0 (en) 1992-11-04 1992-11-04 Chemical compounds
PCT/DK1993/000351 WO1994010139A1 (en) 1992-11-04 1993-11-01 Novel vitamin d analogues

Publications (2)

Publication Number Publication Date
RU95113157A true RU95113157A (ru) 1996-11-20
RU2128168C1 RU2128168C1 (ru) 1999-03-27

Family

ID=10724491

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95113157A RU2128168C1 (ru) 1992-11-04 1993-11-01 Аналоги витамина d3, способы из получения, фармацевтическая композиция и способ лечения

Country Status (16)

Country Link
US (1) US5710142A (ru)
EP (1) EP0667856B1 (ru)
JP (1) JPH08503700A (ru)
KR (1) KR100301214B1 (ru)
AT (1) ATE163007T1 (ru)
AU (1) AU671326B2 (ru)
CA (1) CA2144161A1 (ru)
DE (1) DE69316910T2 (ru)
DK (1) DK0667856T3 (ru)
ES (1) ES2114619T3 (ru)
FI (1) FI109687B (ru)
GB (1) GB9223061D0 (ru)
GR (1) GR3026647T3 (ru)
NZ (1) NZ257533A (ru)
RU (1) RU2128168C1 (ru)
WO (1) WO1994010139A1 (ru)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US6121469A (en) 1993-12-23 2000-09-19 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
GB9611603D0 (en) 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
US5972917A (en) * 1998-05-29 1999-10-26 Bone Care Int Inc 1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
DE60231987D1 (de) * 2001-08-22 2009-05-28 Univ Johns Hopkins 24-schwefel-substituierte 1-alpha-25-dihydroxy-vitamin-d3-analogen
CA2488334C (en) 2002-06-13 2010-12-07 Johns Hopkins University 24-sulfoximine vitamin d3 compounds
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
US8425784B2 (en) * 2007-11-05 2013-04-23 University Of Kansas Ozonolysis reactions in liquid CO2 and CO2-expanded solvents
EA201691980A1 (ru) 2009-01-27 2017-07-31 БЕРГ ЭлЭлСи Способы уменьшения побочных эффектов, связанных с химиотерапией
KR101880032B1 (ko) 2009-08-14 2018-07-20 베르그 엘엘씨 탈모증 치료용 비타민 ｄ3 및 이의 유사체들
CA2913543C (en) 2013-05-29 2024-01-09 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd １α．２５−ジヒドロキシ−２６．２７−ジメチルビタミンＤ↓３
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
JPS6253960A (ja) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd ビタミンｄ↓３の誘導体
WO1987003282A1 (en) * 1985-11-21 1987-06-04 Taisho Pharmaceutical Co., Ltd. Vitamin d3 derivative
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
DE59101738D1 (de) * 1990-02-06 1994-07-07 Schering Ag Seitenketten-homologe Vitamin-D-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate, sowie deren Verwendung als Arzneimittel.
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Also Published As

Publication number Publication date
CA2144161A1 (en) 1994-05-11
KR100301214B1 (ko) 2001-11-22
RU2128168C1 (ru) 1999-03-27
NZ257533A (en) 1997-06-24
FI951968A (fi) 1995-04-25
DE69316910T2 (de) 1998-10-01
FI109687B (fi) 2002-09-30
WO1994010139A1 (en) 1994-05-11
AU5418194A (en) 1994-05-24
GB9223061D0 (en) 1992-12-16
ATE163007T1 (de) 1998-02-15
DK0667856T3 (da) 1998-09-28
US5710142A (en) 1998-01-20
AU671326B2 (en) 1996-08-22
JPH08503700A (ja) 1996-04-23
ES2114619T3 (es) 1998-06-01
EP0667856B1 (en) 1998-02-04
GR3026647T3 (en) 1998-07-31
EP0667856A1 (en) 1995-08-23
FI951968A0 (fi) 1995-04-25
DE69316910D1 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
RU95113157A (ru) Новые аналоги витамина d, способ их получения, фармацевтическая композиция на их основе, способ лечения и профилактики патологических состояний
RU95113480A (ru) Новые аналоги витамина d, способы получения, фармацевтическая композиция, способ лечения
RU94046411A (ru) Производные витамина д, способ их получения, фармацевтическая композиция на их основе и способ ее получения, способ лечения
US5786349A (en) Method for treating chlamydia infectious diseases by rifamycin derivative
FI913812A0 (fi) Menetelmä uusien farmaseuttisesti vaikuttavien vitamiini D analogien valmistamiseksi
JPS5569586A (en) 11* 66 and 22substitutedd11carbaa22penenn 33carboxylic acid
PT723540E (pt) Compostos triciclicos de amida e ureia uteis para inibicao da funcao da g-proteina e para o tratamento de doencas proliferativas.
HU913436D0 (en) Process for the production of amino-cumarane-derivatives and medical preparations containing them
MY134819A (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
ATE290386T1 (de) Verfahren zur herstellung von di-beta-d- glucopyranosylamin-verbindungen zur regulierung von entzündungsprozessen
AU7124391A (en) Condensed thiazole compounds, their production and use
IT1229569B (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
NZ234216A (en) Vitamin d analogues, preparation and pharmaceutical compositions thereof
RU94046456A (ru) Новые аналоги витамина д, способ получения, фармацевтическая композиция, способ лечения
PT93239A (pt) Processo para a preparacao de novos analogos da vitamina "d" e de composicoes farmaceuticas que os contem
RU94046458A (ru) Новые аналоги витамина d, способ получения, фармацевтическая композиция, способ лечения
US5418251A (en) Topical composition for accelerating wound healing
DE3884508T2 (de) Cystein-Derivate mit Expectorans-Wirkung.
EP0737476A2 (en) A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts
RU94042230A (ru) Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии
ZA903111B (en) 2-hydroxy-3-phenoxypropylamino compounds and pharmaceutical compositions containing them
EP0635012A1 (en) UNBRIDGED BIS ARYL CARBINOL DERIVATIVES, COMPOSITIONS AND THEIR USE.
PT98538A (pt) Processo de preparacao de factor de crescimento humano epidermico (hegf) dos seus congeneres e de composicoes farmaceuticas que os contem
IE781858L (en) N-methylene thienamycin derivatives
EP0356137B1 (en) Carbonates of 3-demethylthiocolchicine and N-acyl analogs

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20041102